Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Jurcic

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Current Oncology Reports|August 5, 2003
Monitoring PML-RARalpha in acute promyelocytic leukemiaJoseph G Jurcic
Seminars in Nuclear Medicine|March 17, 2020
Targeted Alpha-Particle Therapy for Hematologic MalignanciesJoseph G Jurcic
Immunotherapy|April 6, 2013
Radioimmunotherapy for hematopoietic cell transplantationJoseph G Jurcic
JAMA Oncology|October 28, 2016
Highlights in Hematologic Malignancy Treatments: Leukemia, Myelodysplastic Syndromes, and Allotransplant-New Drugs on the Horizon for Acute Myeloid LeukemiaJoseph G Jurcic
Journal of Medical Imaging and Radiation Sciences|June 30, 2019
Targeted Alpha-Particle Therapy for Hematologic MalignanciesJoseph G Jurcic
Current Oncology Reports|August 11, 2005
Immunotherapy for acute myeloid leukemiaJoseph G Jurcic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
Androgen Maintenance Therapy for Acute Myeloid LeukemiaJoseph G Jurcic
Current Radiopharmaceuticals|May 26, 2018
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic MalignanciesJoseph G Jurcic
Current Hematologic Malignancy Reports|November 24, 2011
What happened to anti-CD33 therapy for acute myeloid leukemia?Joseph G Jurcic
Clinical Lymphoma|April 24, 2002
Antibody therapy in acute myeloid leukemia: current status and future directionsJohn M Burke, Joseph G Jurcic
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Current Oncology Reports|August 5, 2003
Monitoring PML-RARalpha in acute promyelocytic leukemiaJoseph G Jurcic
Seminars in Nuclear Medicine|March 17, 2020
Targeted Alpha-Particle Therapy for Hematologic MalignanciesJoseph G Jurcic
Immunotherapy|April 6, 2013
Radioimmunotherapy for hematopoietic cell transplantationJoseph G Jurcic
JAMA Oncology|October 28, 2016
Highlights in Hematologic Malignancy Treatments: Leukemia, Myelodysplastic Syndromes, and Allotransplant-New Drugs on the Horizon for Acute Myeloid LeukemiaJoseph G Jurcic
Journal of Medical Imaging and Radiation Sciences|June 30, 2019
Targeted Alpha-Particle Therapy for Hematologic MalignanciesJoseph G Jurcic
Current Oncology Reports|August 11, 2005
Immunotherapy for acute myeloid leukemiaJoseph G Jurcic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
Androgen Maintenance Therapy for Acute Myeloid LeukemiaJoseph G Jurcic
Current Radiopharmaceuticals|May 26, 2018
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic MalignanciesJoseph G Jurcic
Current Hematologic Malignancy Reports|November 24, 2011
What happened to anti-CD33 therapy for acute myeloid leukemia?Joseph G Jurcic
Clinical Lymphoma|April 24, 2002
Antibody therapy in acute myeloid leukemia: current status and future directionsJohn M Burke, Joseph G Jurcic
Pageof 6